Post-menopausal skin change is usually filed under ageing. The data suggests a different clock is running.
Skin collagen loss correlates with menopausal age rather than chronological age — meaning the relevant number isn’t how old you are, but how long it’s been since menopause.
The number, and what it measures
The foundational work here dates to the 1980s and has been reproduced since.
Brincat and colleagues measured skin thickness and collagen content in post-menopausal women across years since menopause[1]. The findings:
- Approximately 30% of dermal collagen is lost in the first five years after menopause[1][2]
- Followed by an average decline of about 1% per post-menopausal year over the subsequent 15 to 20 years[1][6]
- Skin thickness reduces by about 13% per post-menopausal year[2]
Affinito and colleagues confirmed the relationship biochemically, and found it dose-dependent on cumulative oestrogen deficit[2].
The 2025 narrative review in the *Journal of Cosmetic Dermatology* states the indexing plainly: collagen content declines with menopausal age rather than chronological age[6].
That reframing matters. Two women of the same age can be at very different points on this curve depending on when menopause occurred.
What actually changes
The visible changes get the attention, but the structural list is broader — and some of it is functional rather than cosmetic.
A 2025 review summarises the effects of oestrogen deficiency on skin structure[6]:
- Reduced type I and type III collagen — decreased structural integrity and elasticity
- Loss of elastin and hydrophilic glycosaminoglycans — reduced moisture retention
- Reduced sebum production — dryness and increased rigidity
- Reduced vascularity — impaired wound healing and a weakened skin barrier
The last item is the one worth registering. Thinner skin with reduced vascularity bruises more readily, heals more slowly, and provides less barrier protection[5].
So this isn’t purely an appearance question. It’s a tissue that has become structurally different, with consequences for how it handles injury.
Why oestrogen reaches skin at all
The connection is direct, as with the immune changes covered earlier in this series.
Both oestrogen and androgen receptors have been identified on dermal fibroblasts and epidermal keratinocytes[3]. Fibroblasts are the cells that build and maintain the collagen scaffold.
When oestrogen declines, collagen production becomes less efficient while existing collagen breaks down more readily[5]. Breakdown outpaces synthesis.
That imbalance explains the front-loaded curve — the fastest loss occurs when the change in signal is most abrupt, then slows to a steadier rate.
What the hormone evidence shows
The hormone therapy findings here run opposite to what we saw with dry eye, which is worth noting explicitly.
Brincat’s 1983 work found women on hormone therapy had skin collagen content 48% higher than women not on it[3]. Later studies found increases in collagen type I and type III respectively[3].
A 2005 consolidation in the *Journal of the American Academy of Dermatology* concluded that oestrogen treatment in post-menopausal women repeatedly increases collagen content, dermal thickness and elasticity — modestly, but reliably[7].
There’s an interesting baseline dependency. Oestrogen appears to prevent collagen loss in women with higher initial collagen levels, and stimulate synthesis in women with lower initial levels[4].
But the same 2005 source is careful: the exact role of oestrogen on collagen synthesis is not known, and not all studies agree[3].
And to state the obvious: none of this is a recommendation. Hormone therapy involves a risk-benefit assessment across many outcomes, and skin is one small part of it. That’s a clinician’s conversation.
Where collagen supplements sit
Given the topic, this deserves addressing directly.
A 2014 double-blind placebo-controlled trial enrolled 69 women aged 35 to 55, randomised to 2.5 g or 5.0 g of a specific bioactive collagen peptide daily, or placebo, for eight weeks. At eight weeks both peptide groups showed statistically significant improvement in skin elasticity compared with placebo[5].
Set that beside what we covered in the collagen absorption post. The peptides do reach the bloodstream — that’s established. But the cell-culture work supporting the signalling mechanism failed to replicate when the culture serum was found to already contain the peptide in question.
So the position is: modest outcome findings in small trials, with an unsettled mechanism. Neither dismissible nor conclusive.
What can be said with more confidence is that a 30% structural loss over five years is a larger change than any oral supplement has been shown to reverse[7].
What is well supported
Setting aside the contested items, a few things aren’t in dispute.
Sun protection. UV exposure drives the same enzymatic collagen breakdown that oestrogen deficiency has already accelerated[2]. The two mechanisms compound, which makes photoprotection more consequential during this period rather than less.
Topical retinoids increase dermal collagen modestly, and are among the better-evidenced topical interventions[7].
Timing matters more than it usually does. The accelerated loss is concentrated in a specific window. Interventions started before or during that window address a different situation from interventions started a decade later[2].
The bone parallel is real. Skin collagen declines at the same time as bone mineral density, and the fastest bone loss also occurs in the years immediately after menopause[5]. Same hormonal driver, two tissues — which connects to the bone density posts in this series.
Closing
The reframing that stayed with me is the clock.
We describe these changes as ageing, and the data says they’re indexed to something else — years since menopause, dose-dependent on cumulative oestrogen deficit. Chronological age is the wrong variable.
That’s information rather than alarm. It means the change is bounded and predictable rather than open-ended, that its steepest section is a known window, and that the same hormonal shift is doing recognisable work in bone and elsewhere.
It also means the honest answer about what reverses it is narrower than the marketing. A 30% structural loss is a large number, and the interventions with the best evidence are protective rather than restorative.
At a Glance
- Approximately 30% of dermal collagen is lost in the first five years after menopause
- Then about 1% per post-menopausal year over the following 15–20 years
- Skin thickness reduces about 13% per post-menopausal year
- The loss correlates with menopausal age, not chronological age, and is dose-dependent on cumulative oestrogen deficit
- Structural effects include reduced type I and III collagen, elastin and glycosaminoglycan loss, reduced sebum, and reduced vascularity with impaired wound healing
- Oestrogen and androgen receptors sit on dermal fibroblasts and keratinocytes
- Hormone therapy studies show modest but reliable increases in collagen, thickness and elasticity — though the mechanism is not fully understood
- A collagen peptide trial in 69 women found improved elasticity at eight weeks; the underlying mechanism remains unsettled
※ This article describes physiological changes and is for general information only. It does not replace medical advice, and nothing here is a recommendation for or against hormone therapy — that decision spans many outcomes and belongs with your clinician. Collagen-related symptoms overlap with thyroid conditions, autoimmune disease and nutrient deficiencies, so unexplained or rapid skin changes warrant medical assessment rather than self-diagnosis.
References
- “A dermatologist’s opinion on hormone therapy and skin aging”, Fertility and Sterility (Brincat findings; 48% higher collagen on hormone therapy), https://www.sciencedirect.com/science/article/pii/S0015028205010277
- “Recent advances in the anti-aging effects of phytoestrogens on collagen, water content, and oxidative stress”, PMC (skin thickness figures; menopausal versus chronological age), https://pmc.ncbi.nlm.nih.gov/articles/PMC7078862/
- “Perimenopause Skin Changes: What’s Really Happening” (Brincat and Affinito findings; receptor localisation; caveat on unsettled mechanism), North Biomedical, https://northbiomedical.com/articles/perimenopause-skin-changes/
- “Skin collagen changes in post-menopausal women receiving oestradiol gel” (baseline-dependent effect), ScienceDirect, https://www.sciencedirect.com/science/article/abs/pii/0378512287900454
- “Collagen Loss After 40: The Midlife Skin Cliff” (Proksch 2014 trial summary; bone parallel), SECONDSPRING, https://www.secondspringph.com/blogs/news/collagen-cliff-midlife-skin
- Viscomi B, et al. “Managing Menopausal Skin Changes: A Narrative Review of Skin Quality Changes, Their Aesthetic Impact, and the Actual Role of Hormone Replacement Therapy”, Journal of Cosmetic Dermatology 2025, https://onlinelibrary.wiley.com/doi/10.1111/jocd.70393
- “Menopause Face: The Real Reasons Your Skin Changed” (Hall and Phillips 2005 consolidation; what is and isn’t reversible), ClearedRx, https://clearedrx.com/blog/menopause-face/